Pluripotent Stem Cell-Derived Therapies
Each year, more human pluripotent stem cell(hPSC)-derived therapies move toward the clinic, which is why it’s important to stay up-to-date with the latest advancements in the field. Whether you’re just about to start your next project or are well on your way to clinical trials, the big picture of clinical translation in terms of patient safety, cell quality, and physiological relevance should always be top of mind.
Below is a collection of scientific resources to highlight the exciting potential of hPSC-derived therapies.
In this Innovation Showcase presentation, Lynn Csontos demonstrates how º£½ÇÆƽâ°æ can support your project timing, product quality, and overall vision by building quality into our products, processes, and policies. Kimberly Snyder then presents data showing how TeSRâ„¢-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, supports optimized cell quality, improved performance, and reproducibility across all cell lines.
Watch Now >-
How to Scale Up and Differentiate hPSCs in 3D Suspension CultureJoin º£½ÇÆƽâ°æ scientists Tia Sojonky and Sarah McManus to learn all about hPSC scale-up and differentiation in 3D suspension culture. This webinar provides an in-depth look at advanced techniques for scaling up and differentiating hPSCs, with some practical tips for getting started and a 15-minute Q&A session that addresses some of the most pressing questions from the field. -
Tools for Optimizing Human Immune Cell ResearchObtaining consistent and reliable results when culturing immune cells can be challenging. Watch this webinar to discover how to obtain high yields of functional T cells, NK cells, B cells, dendritic cells, and macrophages for your research applications. The speaker, Evan Karas, also explains how to expand primary T cells without feeders or serum. -
Scaling Biomimetic Culture of Pluripotent Stem CellsHear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications. -
Quality by Design: Reagents and Support for hPSC-Derived Cell and Gene TherapiesEach year, more human pluripotent stem cell-derived (hPSC-derived) therapies move towards the clinic, and º£½ÇÆƽâ°æ is committed to supporting researchers from discovery to clinical application. In this Innovation Showcase from ISSCR 2021, Lynn Csontos will demonstrate how we build quality into our products, processes, and policies to support your project timing, product quality, and overall vision. Kimberly Snyder will then present data that shows how TeSRâ„¢-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, can support optimized cell quality, improved performance and reproducibility across all cell lines. -
Cryopreservation and Thawing of Pluripotent Stem Cells: Technical Tips and Media RecommendationsTechnical tip from our dedicated team of Product and Scientific Support specialists -
Derivation and Applications of Human Pluripotent Stem CellsOverview of the derivation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) -
Assessing Morphology of hPSCs Passaged As AggregatesTechnical tip from our dedicated team of Product and Scientific Support specialists
